The Evolving Role of Lenvatinib in the HCC Therapeutic Landscape | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
The Evolving Role of Lenvatinib in the HCC Therapeutic Landscape | …
11 months ago
targetedonc.com
Gemcitabine-Oxaliplatin-Lenvatinib (GEMOX-LEN) For Unresectable Fibrolamellar Carcinoma: Promising Results in First 16 Patients
Gemcitabine-Oxaliplatin-Lenvatinib (GEMOX-LEN) For Unresectable Fi…
1 month ago
fibrofoundation.org
LEAP Study: Lenvatinib Plus Pembrolizumab in Patients With RCC and Brain Metastasis | OncLive
3:52
LEAP Study: Lenvatinib Plus Pembrolizumab in Patients With R…
Mar 8, 2024
onclive.com
Dr. Feldman on Lenvatinib and Pembrolizumab Plus Chemotherapy in NSCLC | OncLive
Dr. Feldman on Lenvatinib and Pembrolizumab Plus Chemothera…
May 23, 2022
onclive.com
Managing Patients on Lenvatinib/Everolimus in mRCC | OncLive
Managing Patients on Lenvatinib/Everolimus in mRCC | …
Jul 30, 2018
onclive.com
Practical Considerations for Using Lenvatinib in HCC | OncLive
Practical Considerations for Using Lenvatinib in HCC | OncLive
Jul 30, 2018
onclive.com
Lenvatinib/Pembrolizumab in RCC: Dosing and Adverse Event Management | OncLive
Lenvatinib/Pembrolizumab in RCC: Dosing and Adverse Event Manag…
Apr 1, 2022
onclive.com
Lenvatinib Plus Pembrolizumab or Everolimus for mRCC | OncLive
May 19, 2021
onclive.com
Wirth Discusses SELECT Trial: Lenvatinib in RAI-Refractory DTC …
May 1, 2024
targetedonc.com
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadju…
2 months ago
targetedonc.com
Study Results: Lenvatinib in Renal Cell Carcinoma | OncLive
Jan 29, 2016
onclive.com
Lenvatinib in Metastatic Renal Cell Carcinoma | OncLive
Dec 19, 2015
onclive.com
Dosing Lenvatinib for First-Line Renal Cell Carcinoma Treatment | …
Apr 19, 2022
cancernetwork.com
Metastatic CRC: Pembrolizumab Plus Lenvatinib | OncLive
2 weeks ago
onclive.com
Impact of Lenvatinib-Pembrolizumab on Clinical Practic…
May 12, 2021
onclive.com
Dr. Levy on Future Research Directions for Lenvatinib in HCC | …
Mar 4, 2021
onclive.com
Sequencing in DTC: Lenvatinib and Sorafenib | OncLive
Apr 1, 2016
onclive.com
Dr. Bastholt on Lenvatinib in Thyroid Cancer | OncLive
Mar 7, 2017
onclive.com
Frontline Lenvatinib in HCC: Study 304 | OncLive
2 weeks ago
onclive.com
Lenvatinib Pembrolizumab as Frontline Therapy for Advanced R…
Mar 7, 2022
onclive.com
Dr. Brose on Lenvatinib in Differentiated Thyroid Cancer | On…
3 weeks ago
onclive.com
Adverse Events Seen With Combination Lenvatinib and Pemb…
Dec 22, 2022
onclive.com
Dr. Bergerot on Improved HRQoL With a Higher Starting Dose of Le…
1 month ago
onclive.com
Dr. Finn on Considerations for Lenvatinib in Liver Cancer | OncLive
Sep 19, 2018
onclive.com
Dr. Wirth Discusses the Safety Profile of Lenvatinib as Seen in th…
Jul 15, 2014
onclive.com
Dr. Marcia Brose Discusses Lenvatinib as a New Option in DT…
Feb 13, 2015
onclive.com
0:45
Dr Lan on the Efficacy of Cadonilimab Plus Lenvatinib in Ad…
11 months ago
onclive.com
Primary Results from the Phase 3 Leap-002 Study: Lenvatinib plus P…
Sep 29, 2022
onclive.com
Dr. Cabanillas on Lenvatinib as First-Line Therapy for Patients Wi…
Feb 20, 2016
onclive.com
2:57
#ESMO20: Watch Zarnie Lwin reporting on key results from: LE…
2K viewsOct 3, 2020
FacebookESMO - European Society for Medical Oncology
See more videos
Static thumbnail place holder